Literature DB >> 19696198

CD43 processing and nuclear translocation of CD43 cytoplasmic tail are required for cell homeostasis.

Wooseok Seo1, Hermann J Ziltener.   

Abstract

The sialomucin CD43 is highly expressed on most hematopoietic cells. In this study, we show that the CD43 ectodomain is shed from murine granulocytes, mast cells, and T cells, but not from macrophages. To study the significance of CD43 shedding, we constructed 2 CD43/34 chimeras in which the CD43 membrane-proximal or transmembrane domain was swapped with the corresponding domain from CD34 that is not shed from cells. Viability of cells that normally shed CD43 was negatively affected when forced to express either of the 2 CD43/34 chimeras, but toxicity was reduced when cells coexpressed wild-type CD43. The CD43 cytoplasmic tail (CD43ct) was found to translocate into the nucleus, and inhibition of either its nuclear translocation or its release by gamma-secretase was proapoptotic. Involvement of CD43 in regulation of apoptosis is consistent with our findings that CD43ct was modified by small ubiquitin-like modifier-1 and was colocalized with promyelocytic nuclear bodies. CD43-deficient cells exhibited reduced levels of promyelocytic nuclear bodies and had increased sensitivity to apoptosis induced by growth factor withdrawal or T-regulatory cell suppression. Taken together, our data indicate an essential function of CD43 processing and nuclear localization of CD43ct in cell homeostasis and apoptosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19696198     DOI: 10.1182/blood-2009-06-228791

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

1.  Analysis of glycoprotein E-selectin ligands on human and mouse marrow cells enriched for hematopoietic stem/progenitor cells.

Authors:  Jasmeen S Merzaban; Monica M Burdick; S Zeineb Gadhoum; Nilesh M Dagia; Julia T Chu; Robert C Fuhlbrigge; Robert Sackstein
Journal:  Blood       Date:  2011-06-09       Impact factor: 22.113

2.  Involvement of indirectly allostimulated CD4+CD43highCD45RO+ T cell proliferation in the development of chronic allograft nephropathy.

Authors:  Yu-Mee Wee; Joo-Hee Jung; Yang-Hee Kim; Monica-Y Choi; Young-Hoon Kim; Do-Sook Choi; Myung-Hwan Cho; Duck-Jong Han
Journal:  Exp Biol Med (Maywood)       Date:  2015-09-07

3.  Mass spectrometry-based identification of the tumor antigen UN1 as the transmembrane CD43 sialoglycoprotein.

Authors:  Annamaria de Laurentiis; Marco Gaspari; Camillo Palmieri; Cristina Falcone; Enrico Iaccino; Giuseppe Fiume; Ornella Massa; Mariorosario Masullo; Franca Maria Tuccillo; Laura Roveda; Ubaldo Prati; Olga Fierro; Immacolata Cozzolino; Giancarlo Troncone; Pierfrancesco Tassone; Giuseppe Scala; Ileana Quinto
Journal:  Mol Cell Proteomics       Date:  2011-03-03       Impact factor: 5.911

4.  Differential Expression of CD43, CD81, and CD200 in Classic Versus Variant Hairy Cell Leukemia.

Authors:  Dalia A Salem; Drake Scott; Catharine S McCoy; David J Liewehr; David J Venzon; Evgeny Arons; Robert J Kreitman; Maryalice Stetler-Stevenson; Constance M Yuan
Journal:  Cytometry B Clin Cytom       Date:  2019-05-11       Impact factor: 3.058

5.  CD43-mediated IFN-γ production by CD8+ T cells promotes abdominal aortic aneurysm in mice.

Authors:  Hui-fang Zhou; Huimin Yan; Judy L Cannon; Luke E Springer; Jonathan M Green; Christine T N Pham
Journal:  J Immunol       Date:  2013-04-12       Impact factor: 5.422

6.  An alternative mode of CD43 signal transduction activates pro-survival pathways of T lymphocytes.

Authors:  Maria Elena Bravo-Adame; Rosario Vera-Estrella; Bronwyn J Barkla; Cecilia Martínez-Campos; Angel Flores-Alcantar; Jose Pablo Ocelotl-Oviedo; Gustavo Pedraza-Alva; Yvonne Rosenstein
Journal:  Immunology       Date:  2016-10-12       Impact factor: 7.397

7.  CD43 interaction with ezrin-radixin-moesin (ERM) proteins regulates T-cell trafficking and CD43 phosphorylation.

Authors:  J L Cannon; P D Mody; K M Blaine; E J Chen; A D Nelson; L J Sayles; T V Moore; B S Clay; N O Dulin; R A Shilling; J K Burkhardt; A I Sperling
Journal:  Mol Biol Cell       Date:  2011-02-02       Impact factor: 4.138

Review 8.  Aberrant glycosylation as biomarker for cancer: focus on CD43.

Authors:  Franca Maria Tuccillo; Annamaria de Laurentiis; Camillo Palmieri; Giuseppe Fiume; Patrizia Bonelli; Antonella Borrelli; Pierfrancesco Tassone; Iris Scala; Franco Maria Buonaguro; Ileana Quinto; Giuseppe Scala
Journal:  Biomed Res Int       Date:  2014-02-13       Impact factor: 3.411

9.  Intracellular patterns of sialophorin expression define a new molecular classification of breast cancer and represent new targets for therapy.

Authors:  Q Fu; S E Cash; J J Andersen; C R Kennedy; A R Madadi; M Raghavendra; L L Dietrich; W A Agger; C S Shelley
Journal:  Br J Cancer       Date:  2013-11-26       Impact factor: 7.640

10.  Characterization of Two Novel mAbs Recognizing Different Epitopes on CD43.

Authors:  Soseul Kim; Jeong Won Hong; Woon-Dong Cho; Yoo Ri Moon; Sang Soon Yoon; Min-Young Kim; Kwon Pyo Hong; Yong-Moon Lee; Jae Hyuk Yi; Young Jun Ham; Hyung Chul Rah; Seung Ryul Kim; Hyung Geun Song
Journal:  Immune Netw       Date:  2014-06-19       Impact factor: 6.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.